English
Современные тенденции в исследовании патогенеза акне
DOI: https://dx.doi.org/10.18565/pharmateca.2021.14.10-14
Е.Е. Сидоренко (1), А.Н. Львов (2)
1) Ростовский государственный медицинский университет, Ростов-на-Дону, Россия; 2) Центральная государственная медицинская академия УДП РФ, Москва, Россия
Литература
1. Самцов А.В., Аравийская Е.Р. Акне и розацеа. М., 2021. С. 7. 2. Tan J.K., Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl. 1):3–12. Doi: 10.1111/bjd.13462. 3. Zeichner J. Acneiform Eruptions in Dermatology. Adifferential. Diagnosis. Springer, N.Y. 2014. P. 3–12. 4. Bellew S., Thiboutot D., Del Rosso J.Q. Pathogenesis of acne vulgaris: what’s new, what’s interesting and what may be clinically relevant. J Drugs Dermatol. 2011;10(6):582–85. 5. Aktan S., Ozmen E., Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol. 2000;39(5):354–57. Doi: 10.1046/j.1365-4362.2000.00907.x. 6. Tanghetti E.A. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2013;6(9):27–35. 7. Jeremy A.H., Holland D.B., Roberts S.G., et al Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–7. Doi: 10.1046/j.1523-1747.2003.12321.x. 8. Львов А.Н., Корнят М.С., Игошина А.В., Назаренко А.Р. Перспективы в терапии акне: аналитический обзор. Клиническая дерматология и венерология. 2019;18(2):115–28. 9. Dreno B., Gollnick H.P., Kang S., et al; Global Alliance to Improve Outcomes in Acne. Understanding innate immunity and inflammation in acne: Implications for management. J Eur Acad Dermatol Venereol. 2015;29(Suppl. 4):3–11. Doi: 10.1111/jdv.13190. 10. Beylot C., Auffret N., Poli F., et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014;28:271–78. Doi: 10.1111/jdv.12224. 11. Valins W., Amini S., Berman B. The expression of Toll-like receptors in dermatological diseases and the therapeutic effect of current and newer topical Toll-like receptor modulators. J Clin Aesthet Dermatol. 2010;3:20–9. 12. Kim J., Ochoa M.T., Krutzik S.R., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169:1535–41. Doi: 10.4049/jimmunol.169.3.1535. 13. Kim J. Review of the innate immune response in acne vulgaris: activation of Toll- like receptor 2 in acne triggers inflammatory cytokine responses. Dermatol. 2005;211:193–98. Doi: 10.1159/000087011. 14. Adisen E., Yuksek J., Erdem O., et al. Expression of human neutrophil proteins in acne vulgaris. J Eur Acad Dermatol Venereol. 2009;24:32–7. Doi: 10.1111/j.1468-3083.2009.03347.x. 15. Salvucci E. Microbiome, holobiont and the net of life. Crit Rev Microbiol. 2016;42:485–94. Doi: 10.3109/1040841X.2014.962478. 16. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science. 2012;336:1268–73. Doi: 10.1126/science.1223490. 17. Cogen A.L., Nizet., Gallo R.L. Skin microbiota: a sourse of disease or defence? Br J Dermatol. 2008;158(3):442–55. Doi: 10.1111/j.1365-2133.2008.08437.x. 18. Dréno B., Dagnelie M.A., Khammari A., Corvec S. The Skin Microbiome: A New Actor in Inflammatory Acne Am J Clin Dermatol. 2020;21(Suppl. 1):18–24. Doi: 10.1007/s40257-020-00531-1. 19. Dreno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;31(Suppl. 5):8–12. Doi: 10.1111/jdv.14374. 20. Gollnick H.P. From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol. 2015;29(Suppl. 5):1–7. Doi: 10.1111/jdv.13186. 21. Deplewski D., Rosenfield R.L. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21:363–92. Doi: 10.1210/edrv.21.4.0404. 22. Akamatsu H., Zouboulis C.C., Orfanos C.E. Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol. 1992;99:509–11. Doi: 10.1111/1523-1747.ep12616181. 23. Schneider M.R., Paus R. Sebocytes, multifaceted epithelial cells: lipid pro- duction and holocrine secretion. Int J Biochem Cell Biol. 2010;42:181–85. Doi: 10.1016/j.biocel.2009.11.017. 24. Thiboutot D., Gollnick H. Nowe spojrzenie na postezpowanie w trazdziku: aktualizacja zalecen Swiatowej Grupy Ekspertow na Rzecz Poprawy Wynikow Leczenia Trazdziku. Dermatol Kosmetol. 2009;9:4–52. 25. Bosanac S.S., Trivedi M., Clark A.K., et al. Progestins and acne vulgaris: a review. Dermatol. On-line J. 2018;24(5):13030/qt6wm945xf. 26. Peigne M., Villers-Capelle A., Robin G., Dewailly D. Hyperandrogenism in women. Presse Med. 2013;42:1487–99. Doi: 10.1016/j.lpm.2013.07.016. 27. Zouboulis C.C., Bornstein S.R. Skin and hormones: news from dermato-endocrinology. Dtsch Med. Wochenschr. 2013;138:1561–63. Doi: 10.1055/s-0033-1343297. 28. Schneider M.R., Paus R. Sebocytes, multifaceted epithelial cells: lipid production and holocrine secretion. Int J Biochem Cell Biol. 2010;42:181–85. Doi: 10.1016/j.biocel.2009.11.017. 29. Isard O., Knol A.C., Aries M.F., et al. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation. J Invest Dermatol. 2011;131:59–66. Doi: 10.1038/jid.2010.281. 30. Jeremy A.H., Holland D.B., Roberts S.G., et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–7. Doi: 10.1046/j.1523-1747.2003.12321.x. 31. Ben-Amitai D., Laron Z. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. J Eur Acad Dermatol Venereol. 2011;25:950–54. Doi: 10.1111/j.1468-3083.2010.03896.x. 32. Melnik B.C. Linking diet to acne metabolomics, inflammation, and comedogenesis: An update. Clin Cosmet Investig Dermatol. 2015;8:371–88. Doi: 10.2147/CCID.S69135. 33. Chiba K., Yoshizawa K., Makino I., et al. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci. 2000;25:77–83. Doi: 10.2131/jts.25.77. 34. Anaba L.E., Ogunbiyi O.A., George O.A. Adolescent Facial Acne Vulgaris and Body Mass Index: Any Relationship? West Afr J Med. 2019;36(2):129–32. 35. Lever L., Marks R. Current views on the aetiology, pathogenesis and treatment of acne vulgaris. Drugs. 1990;39(5):681–92. doi: 10.2165/00003495-199039050-00005. 36. Toyoda M., Nakamura M., Morohashi M. Neuropeptides and sebaceous glands. Eur J Dermatol. 2002;12(5):422–27. 37. Ganceviciene R., Graziene V., Fimmel S., Zouboulis C.C. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol. 2009;160(2):345–52. Doi: 10.1111/j.1365-2133.2008.08959.x. 38. Niemeier V., Kupfer J., Gieler U. Acne vulgaris-Psychosomatische Aspekte 39. Samuels D.V., Rosenthal R., Lin R., et al. Acne vulgaris and risk of depression and anxiety: a meta-analytic review. J Am Acad Dermatol. 2020;83(2):532–41. Doi: 10.1016/j.jaad.2020.02.040. 40. Nguyen C.M., Beroukhim K., Danesh M.J., et al. The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clin Cosmet Investig Dermatol. 2016;9:383–92. Doi: 10.2147/CCID.S76088. 41. Pagliarello C., Di Pietro C., Tabolli S. A comprehensive health impact assessment and determinants of quality of life, health and psychological status in acne patients. J Ital Dermatol Venereol. 2015;150(3):303–8.
Об авторах / Для корреспонденции
Автор для связи: Елизавета Евгеньевна Сидоренко, врач-дерматолог, Центр внутренних болезней, лаборант кафедры кожных и венерических болезней, Ростовский государственный медицинский университет, Ростов-на-Дону, Россия; okt@rostgmu.ru ORCID:
Е.Е. Сидоренко, https://orcid.org/0000-0002-9954-2920
А.Н. Львов, https://orcid.org/0000-0002-3875-4030
Похожие статьи
При полном или частичном использовании материалов ссылка на журнал «ФАРМАТЕКА» обязательна.
